Y A Kucheryavyy

49PUBLICATIONS
157CO-AUTHORS
PharmacogenomicsBehavioural epidemiologyEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Sep 26, 2026
Efficacy of Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors in Eradication Regimens for Clarithromycin-Resistant Helicobacter pylori: A Systematic Review and Meta-Analysis.

|Jun 26, 2026
Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).

|May 04, 2026
Efficacy and Safety of Tegoprazan in Helicobacter pylori Eradication: An Umbrella Review of Meta-Analyses.

|Jan 28, 2026
Rebamipide as an Adjunctive Therapy for Gastrointestinal Diseases: An Umbrella Review.

Igor V Maev, Alsu R Khurmatullina, Dmitrii N Andreev

|Oct 28, 2025
Tailored Therapy vs. Empirical Therapy for Helicobacter pylori Eradication: An Umbrella Review of Systematic Reviews and Meta-Analyses.

Dmitrii N Andreev, Alsu R Khurmatullina, Igor V Maev

|Aug 30, 2025
[Study on the efficacy of combination therapy with rifaximin and Saccharomyces boulardii CNCM I-745 in patients with small intestinal bacterial overgrowth associated with long-term use of proton pump inhibitors].

I V Maev, D N Andreev, R I Shaburov

Pageof 9

Frequent Collaborators

36 joint publications

Igor V Maev

17 joint publications

Dmitry S Bordin

16 joint publications

Yury A Kucheryavyy

12 joint publications

Philipp S Sokolov